The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

Diagnostics' products, including its in-development point-of-care molecular diagnostics system, in Saudi Arabia and 18 other MENA countries.

The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

Last week, readers were most interested in a story about Hologic's plans to go private via an acquisition by two private equity firms.

The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.

The blood-based test detects phosphorylated tau 181, a biomarker that is correlated with the presence of amyloid pathology in ...

As the shutdown drags out, there could be delays in regulatory processes and payments for medical services as well as the ...

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...

Researchers hope to soon commercialize a simple, inexpensive, and accessible screening test that uses taste as a detection ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

For the third quarter Roche's diagnostics division revenues dropped 5 percent year over year led by a decline in near-patient care revenues.

The deal involves the installation of 24 of Diasorin's Liaison Plex instruments at Quest labs and the supply of respiratory panel tests during flu season.